Complement-related diseases

Allergy and Asthma Proceedings

Volumn 23, Issue 5, 2002, Pages 319-324

  Frieri, Marianne ^a  

^a NASSAU UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT;

APOPTOSIS; COMMUNICABLE DISEASE; GENETICS; HUMAN; IMMUNOLOGY; IMMUNOPATHOLOGY; REVIEW;

APOPTOSIS; COMMUNICABLE DISEASES; COMPLEMENT SYSTEM PROTEINS; HUMANS; IMMUNE SYSTEM DISEASES;

EID: 0036726034     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Walport MJ Complement advances in immunology. First of two parts. N Engl J Med 344:1058-1066, 2001.
2. Frank MM, and Fries LF. The role complement in inflammation and phagocytosis. Immunol Today 12:322-326, 1991.
3. Huston DP Biology of the immune system. JAMA 278:1804-1814, 1997.
4. Figuera JE, and Densen P. Infectious diseases associated with complement deficiencies. Clin Microbiol Rev 4:359-395, 1991.
5. Berliner S. Familial systemic lupus erythematosus and C4 deficiency. Scand J Rheumatol 10:280-282, 1981.
6. Glass D. Inherited deficiency of the second component-complement. Rheumatic Disease Association. J Clin Invest 58:853, 1976.
7. Huston DP, and Bressler RB. Urticaria and angioedema. Med Clin North Am 76.805-840, 1992.
8. Konoshita T, Medof ME, Silber R, et al. Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria. J Exp Med 162: 75-92, 1985.
9. Turner MW. Mannose-binding lectin. the plunpotent molecule of the innate immune system. Immunol Today 17:532-540, 1996.
10. Stahl PD. and Ezekowitz RA. The mannose receptor is a pattern recognition receptor involved in host defense. Curr Opin Immunol 10:50-55, 1998.
11. Summerfield JA, Sumiya M, Levin M. and Turner MW Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. BMJ 314:1229-1232, 1997.
12. Hoal-Van Helden EG, Epstein J. Victor TC, et al. Mannose-binding protein B allele confers protection against tuberculous meningitis. Pediatr Res 45:459-464, 1999.
13. Bellamy R. Ruwende C, McAdam KP, et al. Mannose binding protein deficiency is not associated with malaria, hepatitis B carriage, nor tuberculosis in Africans. Q J Med 91:13-18, 1998.
14. Tanner J, Weis J, Fearon D. et al. Epstein-Barr virus gp 350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis. Cell 50:203-213, 1987.
15. Nemerow GR, Mold C, Schwend VK, et al Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBVI to the EBV/C3d receptor of B cells, sequence homology of gp350 and C3 complement fragment C3d. J Virol 61:1416-1420. 1987.
16. Frieri M. Blau S, Sullivan J. Tiger L, et al. Immunoregulatory detects in chronic Epstein-Barr virus infection. J Allergy Clin Immunol 79:226a, 1987.
17. Schorey JS, Carroll MC, and Brown EJ. A macrophage invasion mechanism of pathogenic mycobacteria. Science 277.1091-1093, 1997.
18. Speth C, Kacani L, and Dierich MP. Complement receptors in HIV infection. Immunol Rev 159:49-67, 1997.
19. Therattil J. and Frieri M. Allergic rhinitis in HIV-infected patients. Immunol Allergy Clin North Am 17:291-301, 1997
20. Mansur A. Chu CM. Karnick A. and Frieri M. Nitric oxide production and apoptosis by gp 120. Allergy Asthma Proc 21:145-149, 2000.
21. Shum JC, and Frieri M. Evaluation, apoptosis and autoimmune diseases. Pediatr Asthma Allergy Immunol 11.9-16, 1997.
22. Wu J, Zhou T, Zhang J, and Croce M. Correction of accelerated autoimmune disease by early replacement of the mutated lpr gene with normal Fas apoptosis gene in the T cells of transgenic MRL-lpr/lpr mice. Proc Natl Acad Sci USA, 91:2344-2348.
23. Mountz JD, Zhou T. Wu J, et al Regulation of apoptosis in immune cells. J Clin Immunol 15:1-16, 1995.
24. Fisher GH, Rosenberg FJ, Strause SE, et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferation syndrome. Cell 81:935-946, 1995.
25. Rieux-Laucat F, Le Diest C. Hivoriz IAG, et al Mutation in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347-1349, 1995.
26. Drappa J, Valshnaw AK, Sullivan KE, et al. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N Engl J Med 335:1643-1649, 1996.
27. Sneller MC, Straus SE, Jaffe ES, et al. A novel lymphoproliferalive/ autoirnmune syndrome resembling murine lpr/gld disease. J Clin Invest 90:334-341, 1992.
28. Kazatchkine MD, and Kaveri SV. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin N Engl J Med 345:747-755, 2001.
29. Cosachov J, and Frieri M. Hyper-IgM syndrome with congenital rubella. Pediatr Asthma Allergy Immunol 9:79-85, 1995.
30. Mansur A. Therattil J, Young R. and Frieri M. An atypical case of hypogammaglobulinemia. Ann Allergy Asthma Immunol 84:583-586, 2000.
31. Walport MJ, Complement Advances in Immunology second of two parts. Complement at the interface between innate and adaptive immunity. N Engl J Med 344:1140-1144, 2001.
32. Frieri M. Angadi C. Paolano A, et al. Altered T-cell subpopulations and lymphocytes expressing natural killer cell phenotypes in patients with progressive systemic sclerosis J Allergy Clin Immunol 87:773-779, 1991.
33. Frieri M. Systemic sclerosis. The role of the mast cell and cytokines. Ann Allergy 69:385-397, 1992.
34. Siegert CE, Kazatchkine MD, Sjoholm A. et al. Autoantibodies against CIq. view in clinical relevance and pathogenic role. Clin Exp Immunol 116:4-8, 1999.
35. Kikuchi Y, and Kaplan AP. Mechanisms of autoimmune activation of basophils. in chronic urticaria. J Allergy Clin Immunol 107:1056-1062, 2001.
36. Kamradt T, and Mitchison NA. Tolerance and autoimmunity. N Engl J Med 344:655-664, 2001.
37. Frieri M. New frontiers in immunotherapy. Allergy Asthma Proc 20.281-288, 1999.